A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment

Contemporary Clinical Trials
Michael S GordonKevin E O'Grady

Abstract

Buprenorphine can be effective in a variety of community substance use treatment settings outside of methadone programs, including outpatient programs and medical practices. In these settings, it has been found to be effective in reducing opioid use and retaining patients in treatment. Despite its effectiveness and safety, it is rarely provided to individuals with opioid use disorders in probation and parole settings. Male and female individuals under probation or parole supervision (N = 320) with histories of opioid use disorder will be enrolled in this randomized controlled trial. Participants will be randomized to one of two study arms: Buprenorphine Bridge Treatment (BBT): Participants will begin buprenorphine using the MedicaSafe dispensing device immediately after an on-site intake at a community supervision office and continue such treatment until they are transitioned to a community program; or Treatment as Usual (TAU): Participants will receive a referral to buprenorphine pharmacotherapy treatment in the community. Treatment outcomes will be: (a) illicit opioid oral saliva drug test results; and (b) treatment adherence (i. entered community based treatment; ii. number of days receiving opioid treatment). We describe th...Continue Reading

Citations

Nov 5, 2021·Journal of Addiction Medicine·Sarah Kattakuzhy, Elana Rosenthal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Related Papers

Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse
Michael S GordonHamin Shabazz
International Review of Psychiatry
Robert P SchwartzJerome H Jaffe
© 2022 Meta ULC. All rights reserved